Continuous production of manganese peroxidase by Phanerochaete chrysosporium immobilized on polyurethane foam in a pulsed packed-bed bioreactor. 1997

M T Moreira, and G Feijoo, and C Palma, and J M Lema
Department of Chemical Engineering, University of Santiago de Compostela, E-15706 Santiago de Compostela, Galiza, Spain.

The bottleneck of the application of manganese peroxidase (MnP) on an industrial scale in pulp biobleaching or in degradation of hazardous compounds is the lack of an efficient production system. Three main problems arise for the continuous production of MnP during secondary metabolism of Phanerochaete chrysosporium: enzyme production occurs only under specific physiological conditions corresponding to C or N limitation, high O(2) tension, and adequate Mn(+2) concentration; the enzyme that is produced is destabilized by extracellular proteases; and excessive growth of the mycelium blocks effective oxygen transfer. To overcome these drawbacks, continuous production of MnP was optimized by selecting a suitable bioreactor configuration and the environmental and operating conditions affecting both enzyme production and stability. The combination between a proper feed rate and the application of a pulsation in a packed-bed bioreactor permitted the maintenance of continuous secretion of MnP while limiting mycelial growth and avoiding bed clogging. Environmental factors as an Mn(+2) concentration of 5000 microM and high oxygen tension enhanced MnP production. The hydraulics of the bioreactor corresponding to a plug flow model with partial mixing and an operating hydraulic rentention time of 24 h were optimal to achieve stable operating conditions. This policy allowed long operation periods, obtaining higher productivities than the best reported in the literature. (c) 1997 John Wiley & Sons, Inc. Biotechnol Bioeng 56: 130-137, 1997.

UI MeSH Term Description Entries

Related Publications

M T Moreira, and G Feijoo, and C Palma, and J M Lema
January 2008, Preparative biochemistry & biotechnology,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
August 1996, Biotechnology and bioengineering,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
June 2011, Applied biochemistry and biotechnology,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
February 2019, Bioresource technology,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
June 1990, Journal of bacteriology,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
July 1991, Journal of bacteriology,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
January 2003, Biotechnology progress,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
November 2014, Applied microbiology and biotechnology,
M T Moreira, and G Feijoo, and C Palma, and J M Lema
November 2021, Molecules (Basel, Switzerland),
M T Moreira, and G Feijoo, and C Palma, and J M Lema
August 2003, Artificial cells, blood substitutes, and immobilization biotechnology,
Copied contents to your clipboard!